🇺🇸 14-day Cerebrolysin treatment in United States

14-day Cerebrolysin treatment (14-day Cerebrolysin treatment) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

14-day Cerebrolysin treatment in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 14-day Cerebrolysin treatment approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 14-day Cerebrolysin treatment in United States?

Cardinal Stefan Wyszynski University is the originator. The local marketing authorisation holder may differ — check the official source linked above.